Connected: Diabetes Data Management Made Easy

New software solutions that communicate between differing brands of meters, monitors, and pumps make downloading a patient’s glucose data less time consuming for both physician and patient.

Imagine the following: you are caring from someone with a chronic, 24/7 disease where patients are asked to self-administer a potentially deadly drug every day, and you are only given twenty minutes with your patient a few times a year.

Oh, that’s right — you don’t have to imagine it. It’s type 1 diabetes.

The Problem

A physician can only do so much for someone with type 1 diabetes in a short office visit. David Ahn, MD, a clinical instructor of endocrinology at UCLA, knows this burden well. “In my endocrinology practice, type 1 diabetes easily represents my biggest time management challenge,” he says. “Unfortunately, it’s almost a given that these visits will either run over time or end with some topics left unaddressed.”

Ahn’s words capture the whirlwind of challenges confronting endocrinologists seeing patients with diabetes. For one, the patient population is growing quickly; the International Diabetes Federation (IDF) has predicted that by 2035, the number of people with diabetes will near 600 million, a roughly 50% increase relative to its 2014 estimate of 400 million. Meanwhile, there is a shortage of endocrinologists. According to studies from the 2014 Center for Disease Control National Diabetes Statistic Report and The Journal of Clinical Endocrinology & Metabolism, there is one endocrinologist for every 4,117 diabetes patients in the U.S. The cost of care has also become a huge problem for patients and the healthcare system; according to the IDF, diabetes expenditures in the U.S. reached $612 billion in 2014. In short, endocrinologists have less time and fewer resources for patients than ever before.

Data Downloading

One aspect of care that often proves troublesome is data downloading. At the American Association of Diabetes Educators 2014 meeting, a poll revealed that only 5% of the 400 attendees worked with physician providers who routinely download continuous glucose monitors (CGM) and pump data. “We are constantly pressured to do more in shorter visits,” Ahn says. “Something has to give, and it’s often the downloading of glucose data.”

Historically, the challenge of data downloading has been that information on blood glucose meters (BGM), CGMs, and insulin pumps have been handled in a very siloed way. Companies have designed devices to work only with proprietary hardware and software, making it inconvenient to download in the first place and even more difficult to integrate data from different devices (e.g., a pump and a meter).

“It is difficult to convince physicians that downloading actually improves care and saves time in the long run. This is especially true for those providers who were not introduced to the benefits of downloading in their training.”

— Irl Hirsch, MD, professor of medicine at the University of Washington School of Medicine in Seattle, endocrinologist at the University of Washington

As a result, the process of downloading glucose data can be time-consuming and frustrating. Endocrinologists do not have time to fumble with what is often unwieldy software to download these data. This sentiment is well captured by Irl Hirsch, MD, professor of medicine at the University of Washington School of Medicine in Seattle, and an endocrinologist at the University of Washington. “It is difficult to convince physicians that downloading actually improves care and saves time in the long run,” he says. “This is especially true for those providers who were not introduced to the benefits of downloading in their training. And for those who do understand the benefits of downloading, they work in clinics or offices without an infrastructure to do it efficiently and the frustration can be just as great.”

A Solution

Hirsch’s dilemma is a reminder that providers need convenient data download and interpretation solutions. This is where data management platforms come in; these “device-agnostic” systems reflect a growing trend in diabetes. They refer to software and hardware solutions that help download and consolidate data from multiple BGMs, CGMs, and insulin pumps into a single, standardized report. While currently available software and cables are often not interoperable, device agnostic data systems solve this problem by providing a single hardware/software solution that can download and integrate data from multiple devices.

In recent years, three companies have emerged with the goal of making data access easier and more convenient. After all, having this data is key to clinical decision-making.They provide a way of looking at what actually happened, not just what patients can remember.

diasenddiasend: diasend is a universal platform that enables providers to connect blood glucose meters, continuous glucose monitors, and insulin pumps to a single piece of mobile-enabled hardware that instantly uploads data online, thus eliminating any need for software to be installed at the clinic. The diasend system boasts over 100 compatible devices and consolidates the information into a structured web-based report, no matter what the device or how the data are stored. The system also has an accompanying personal version that allows patients to upload the data at home using the software diasend Uploader (Mac and PC compatible) to upload and share data online with providers.

glooko-iphone-meter-740Glooko: Glooko’s MeterSync Blue is another piece of hardware that enables patients to upload data via Bluetooth from over 30 glucose meters (~90% of the market) to Android and Apple apps. When a patient or provider wants to download data, they simply plug MeterSync Blue adapter into their meter and results are sent wirelessly to the app. Integration with insulin pumps and CGMs is not currently available but is in the works. Notably, the MeterSync Blue adapter can be left plugged in all the time, a patient convenience that essentially transforms those meters into 24/7 Bluetooth-enabled devices.

BLIPTidepool: Tidepool is developing a web-based hub for diabetes data called Blip. It takes data from most BGMs, CGMs, and insulin pumps and consolidates that data into a single consolidated report. Tidepool is also working to develop the Tidepool Uploader, web-based software that will connect with multiple devices and upload the data, eliminating the need for unique software for every single device. The Tidepool Uploader will support devices from Abbott, Bayer, Dexcom, Insulet, LifeScan, Medronic, and Tandem. Blip and the Tidepool Uploader are not yet available commercially, but they are slated for release soon. Tidepool is a 501c3 non-profit entity that intends to offer its software for free to patients and providers. In addition to offering Blip for data viewing, Tidepool will enable users to see their data in an eco-system of apps, fostering choice and interoperability.

Focusing on the Patient

While we have largely focused on providers, patients need more convenient data downloads as well. After all, they can enhance self-management and allow patients to begin to own their diabetes. The need for better solutions is well evidenced by data from the T1D Exchange Clinic Registry. This registry is made up of 26,000+ individuals with type 1 diabetes who range in age, at time of enrollment, from less than one year to 93 years. Even in this group that represents some of the most engaged type 1 patients, more than 50% of pump/BGM/CGM users never upload their data, and less than 10% upload their data more than once per week. Many patients may be weighing the decision of whether to upload their data and concluding that the hassle is too great.

Data uploading platforms have the potential to facilitate better decision-making, tighten patient-provider feedback loops, and inform more holistic self-management. They represent a new tool in the diabetes toolkit.

Of course, these platforms don’t solve the all the challenges confronting diabetes treatment and management, but they can make those challenges a little bit more manageable.

—Varun Iyengar is an associate at Close Concerns, a healthcare information company located in San Francisco. He writes about diabetes technology and digital health.

You may also like

  • Standardized Testing: Universal Risk Stratification System Needed for Thyroid Nodules

    With thyroid cancer patients often getting different — and sometimes conflicting — treatment recommendations from a variety of diagnostic tools, Priyanka Majety, MD, talks to Endocrine News about why it’s time for clinicians to coalesce around a single set of standards for these cases, which could potentially eliminate unnecessary procedures. Priyanka Majety, MD, assistant professor…

  • Molecular Testing and the Future of Diagnosing Thyroid Cancer

    Endocrine Society member and medical director for Endocrinology for Veracyte, Joshua Klopper, MD, talks to Endocrine News about a new tool that may have the potential to guide thyroid cancer management decisions by predicting tumor behavior via molecular signatures. In “New Data Presented at the 2023 ATA Annual Meeting Demonstrate that Veracyte’s Afirma-Based Testing Can…